DK0970955T3 - Paroxetin-methansulfonat - Google Patents
Paroxetin-methansulfonatInfo
- Publication number
- DK0970955T3 DK0970955T3 DK99303151T DK99303151T DK0970955T3 DK 0970955 T3 DK0970955 T3 DK 0970955T3 DK 99303151 T DK99303151 T DK 99303151T DK 99303151 T DK99303151 T DK 99303151T DK 0970955 T3 DK0970955 T3 DK 0970955T3
- Authority
- DK
- Denmark
- Prior art keywords
- paroxetine methanesulfonate
- paroxetine
- methanesulfonate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9814316.7A GB9814316D0 (en) | 1998-07-02 | 1998-07-02 | Novel compounds |
GBGB9821732.6A GB9821732D0 (en) | 1998-10-06 | 1998-10-06 | Novel compound |
GBGB9902935.7A GB9902935D0 (en) | 1999-02-10 | 1999-02-10 | Novel compound |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0970955T3 true DK0970955T3 (da) | 2000-10-09 |
Family
ID=27269380
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99918159T DK1089996T3 (da) | 1998-07-02 | 1999-04-23 | Paroxetin-methansulfonat-acetonitril-solvat 1:1 |
DK99303151T DK0970955T3 (da) | 1998-07-02 | 1999-04-23 | Paroxetin-methansulfonat |
DK199900554A DK199900554A (da) | 1998-07-02 | 1999-04-23 | Paroxetinsalte, fremgangsmåde til fremstilling deraf, farmaceutiske præparater omfattende disse og anvendelser deraf |
DK199900176U DK199900176U3 (da) | 1998-07-02 | 1999-04-23 | Paroxetinsalte, farmaceutisk præparat indeholdende disse og anvendelser deraf |
DK199900234U DK199900234U4 (da) | 1998-07-02 | 1999-06-15 | Paroxetin-methansulfonat i krystallinsk form, farmaceutisk præparat indeholdende dette og andvendelse af forbindelsen til f |
DK00201290T DK1020464T3 (da) | 1998-07-02 | 2000-04-10 | Paroxetin-methansulfonat |
DK200000390U DK200000390U1 (da) | 1998-07-02 | 2000-12-27 | Farmaceutiske præparater til oral indgivelse, der omfatter paroxetin-methansulfonat. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99918159T DK1089996T3 (da) | 1998-07-02 | 1999-04-23 | Paroxetin-methansulfonat-acetonitril-solvat 1:1 |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK199900554A DK199900554A (da) | 1998-07-02 | 1999-04-23 | Paroxetinsalte, fremgangsmåde til fremstilling deraf, farmaceutiske præparater omfattende disse og anvendelser deraf |
DK199900176U DK199900176U3 (da) | 1998-07-02 | 1999-04-23 | Paroxetinsalte, farmaceutisk præparat indeholdende disse og anvendelser deraf |
DK199900234U DK199900234U4 (da) | 1998-07-02 | 1999-06-15 | Paroxetin-methansulfonat i krystallinsk form, farmaceutisk præparat indeholdende dette og andvendelse af forbindelsen til f |
DK00201290T DK1020464T3 (da) | 1998-07-02 | 2000-04-10 | Paroxetin-methansulfonat |
DK200000390U DK200000390U1 (da) | 1998-07-02 | 2000-12-27 | Farmaceutiske præparater til oral indgivelse, der omfatter paroxetin-methansulfonat. |
Country Status (35)
Country | Link |
---|---|
US (4) | US6063927A (he) |
EP (5) | EP0970955B1 (he) |
JP (1) | JP2002519422A (he) |
KR (1) | KR20010053336A (he) |
CN (1) | CN1127502C (he) |
AR (2) | AR011759A1 (he) |
AT (4) | AT3185U3 (he) |
AU (4) | AU713877B3 (he) |
BE (3) | BE1011664A6 (he) |
BR (1) | BR9911682A (he) |
CA (1) | CA2269999A1 (he) |
CH (1) | CH689805A8 (he) |
DE (5) | DE19918588A1 (he) |
DK (7) | DK1089996T3 (he) |
ES (4) | ES2209428T3 (he) |
FI (2) | FI112077B (he) |
FR (2) | FR2780728B1 (he) |
GB (5) | GB2352395B (he) |
GR (3) | GR990100140A (he) |
HK (1) | HK1037877A1 (he) |
HU (1) | HUP0102334A3 (he) |
IE (5) | IE20000633A1 (he) |
IL (1) | IL140628A (he) |
IT (1) | IT1312540B1 (he) |
LU (1) | LU90388B1 (he) |
NL (4) | NL1011874C1 (he) |
NO (1) | NO319030B1 (he) |
NZ (1) | NZ509180A (he) |
PL (1) | PL345214A1 (he) |
PT (4) | PT1020464E (he) |
SE (1) | SE9901462A0 (he) |
SI (3) | SI1020464T1 (he) |
SK (1) | SK20262000A3 (he) |
TR (1) | TR200100054T2 (he) |
WO (1) | WO2000001694A1 (he) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998401A (en) * | 1995-02-28 | 1999-12-07 | Eli Lilly And Company | Naphthyl compounds, intermediates, compositions, and methods |
WO1998037938A1 (fr) * | 1997-02-27 | 1998-09-03 | Ajinomoto Co., Inc. | Appareil et procede de cristallisation |
EE03970B1 (et) * | 1997-06-10 | 2003-02-17 | Synthon B.V. | 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim |
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
US20040028582A1 (en) * | 1999-03-10 | 2004-02-12 | Smithkline Beecham Corporation | Crystallization process for producing fine crystal products |
USPP12225P2 (en) | 1999-06-01 | 2001-11-27 | Florfis Ag | Geranium plant named ‘Fislamda’ |
ES2159260B1 (es) * | 1999-06-22 | 2002-05-01 | Smithkline Beechan Plc | Nueva composicion de metanosulfonato de paroxetina |
WO2000078290A2 (en) * | 1999-06-22 | 2000-12-28 | Smithkline Beecham P.L.C. | Pharmaceutical composition comprising a salt of paroxetine |
GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
US6306435B1 (en) | 2000-06-26 | 2001-10-23 | Yung Shin Pharmaceutical Industrial Co. Ltd. | Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same |
GB0015981D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
WO2003079972A2 (en) | 2002-02-22 | 2003-10-02 | New River Parmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
JP2004507504A (ja) * | 2000-08-28 | 2004-03-11 | シントン・ベスローテン・フェンノートシャップ | パロキセチン組成物およびその製造方法 |
DE20100529U1 (de) * | 2001-01-11 | 2001-05-10 | Synthon Bv | Pharmazeutische Tablette umfassend Paroxetinmesylat |
NL1017421C2 (nl) * | 2001-02-21 | 2002-01-15 | Synthon Bv | Werkwijze voor het vervaardigen van paroxetine. |
US20040225128A1 (en) * | 2001-08-02 | 2004-11-11 | Callewaert George Leo | Paroxetine isethionate salt, process of preparation and use in the treatment of depression |
US20050266082A1 (en) * | 2004-05-26 | 2005-12-01 | Patel Satishkumar A | Preparation of stable paroxetine HC1 ER tablets using a melt granulation process |
US20060063737A1 (en) * | 2004-08-18 | 2006-03-23 | Holmdahl Lisa K | Liquid paroxetine compositions |
EP1791531A1 (en) * | 2004-08-20 | 2007-06-06 | Alpharma, Inc. | Paroxetine formulations |
KR100672184B1 (ko) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | 파록세틴의 콜린산 또는 콜린산 유도체 염 |
EP1874908B1 (en) * | 2005-04-07 | 2014-06-11 | Xy, Llc | Method for reducing microorganisms in a flow path using diacetone alcohol |
US20070112031A1 (en) * | 2005-11-14 | 2007-05-17 | Gant Thomas G | Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
EP1966192B1 (en) * | 2005-12-01 | 2012-10-17 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
JP2010520879A (ja) * | 2007-03-09 | 2010-06-17 | ノバルティス アーゲー | 3−(1h−インドール−3−イル)−4−[2−(4−メチル−ピペラジン−1−イル)−キナゾリン−4−イル]−ピロール−2,5−ジオンの塩 |
US8119688B2 (en) * | 2007-09-19 | 2012-02-21 | Xy, Llc | Differential evaporation potentiated disinfectant system |
US20100249166A1 (en) * | 2007-09-19 | 2010-09-30 | Xy, Inc. | Differential evaporation potentiated disinfectant system |
FR2926552B1 (fr) * | 2008-01-23 | 2010-03-26 | Biocodex | Procede de preparation de particules de stiripentol ayant une granulometrie definie |
CN103961333B (zh) * | 2014-05-07 | 2020-02-21 | 浙江华海药业股份有限公司 | 甲磺酸帕罗西汀胶囊及其制备方法 |
CN104523645A (zh) * | 2014-11-20 | 2015-04-22 | 美吉斯制药(厦门)有限公司 | 甲磺酸帕罗西汀片芯及其包衣片的制备方法 |
US11111373B2 (en) | 2018-12-05 | 2021-09-07 | Chi Mei Corporation | Polymethacrylate composition and optical device made therefrom, and display apparatus |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE99678C (he) * | ||||
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
US4585777A (en) * | 1984-02-07 | 1986-04-29 | A/S Ferrosan | (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT |
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
EP0190496A3 (en) * | 1984-12-13 | 1987-05-27 | Beecham Group Plc | Piperidine derivatives having a gastro-intestinal activity |
GB8520154D0 (en) * | 1985-08-10 | 1985-09-18 | Beecham Group Plc | Chemical process |
DE3680184D1 (de) * | 1985-08-10 | 1991-08-14 | Beecham Group Plc | Verfahren zur herstellung von arylpiperidincarbinol. |
EP0223430B1 (en) * | 1985-10-21 | 1991-02-27 | Honda Giken Kogyo Kabushiki Kaisha | Method for controlling the solenoid current of a solenoid valve which controls the amount of suction of air in an internal combustion engine |
EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
IE66332B1 (en) * | 1986-11-03 | 1995-12-27 | Novo Nordisk As | Piperidine compounds and their preparation and use |
GB8626936D0 (en) * | 1986-11-11 | 1986-12-10 | Ferrosan As | Treatment |
JPS63141967A (ja) * | 1986-11-21 | 1988-06-14 | エイ・エッチ・ロビンス・カンパニー・インコーポレーテッド | 抗アレルギー薬として有用な1−アリールオキシー4−[(4−アリール)−1−ピペラジニル]−2−ブタノール |
GB8714707D0 (en) * | 1987-06-23 | 1987-07-29 | Beecham Group Plc | Chemical process |
DK715988D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Etherifikation og dealkylering af piperidin-derivater samt intermediater |
DK716088D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Reduktion af piperidin-dion-derivater samt intermediat |
WO1992009281A2 (en) * | 1990-11-24 | 1992-06-11 | Beecham Group Plc | Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
GB9209687D0 (en) * | 1992-05-06 | 1992-06-17 | Smithkline Beecham Plc | Novel process |
US5258517A (en) * | 1992-08-06 | 1993-11-02 | Sepracor, Inc. | Method of preparing optically pure precursors of paroxetine |
JP2773587B2 (ja) * | 1992-11-30 | 1998-07-09 | 東レ株式会社 | O,o´−ジアシル酒石酸無水物の製造法 |
US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
US5546683A (en) * | 1993-09-29 | 1996-08-20 | Clark; George J. | Bucket attachment device with remote controlled retractable pins |
IT1274241B (it) * | 1993-12-03 | 1997-07-15 | Smithkline Beecham Farma | Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono |
GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
US5668134A (en) * | 1994-01-28 | 1997-09-16 | G. D. Searle & Co. | Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications |
GB9402029D0 (en) * | 1994-02-03 | 1994-03-30 | Smithkline Beecham Plc | Novel formulation |
CA2143070C (en) * | 1994-02-22 | 2001-12-18 | Pankaj Modi | Oral controlled release liquid suspension pharmaceutical formulation |
EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
AR001982A1 (es) * | 1995-02-06 | 1998-01-07 | Smithkline Beecham Plc | Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion |
GB2297550C2 (en) * | 1995-02-06 | 1997-04-09 | Smithkline Beecham Plc | Paroxetine hydrochloride anhydrate substantially free of bound organic solvent |
WO1996031197A1 (en) * | 1995-04-03 | 1996-10-10 | Abbott Laboratories | Homogeneous mixtures of low temperature-melting drugs and additives for controlled release |
CN1068597C (zh) * | 1995-05-17 | 2001-07-18 | 诺沃挪第克公司 | 制备4-芳基-哌啶衍生物的方法 |
JP2813768B2 (ja) * | 1995-05-24 | 1998-10-22 | 農林水産省家畜衛生試験場長 | 口蹄疫診断用ペプチドおよび当該ペプチドを含有する口蹄疫診断用抗原 |
GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
WO1997016448A1 (en) * | 1995-10-31 | 1997-05-09 | Merck & Co., Inc. | Process for preparing substituted azetidinones |
IT1276160B1 (it) * | 1995-11-22 | 1997-10-27 | Recordati Chem Pharm | Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee |
GB9526645D0 (en) * | 1995-12-28 | 1996-02-28 | Chiroscience Ltd | Stereoselective synthesis |
ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
JP3446468B2 (ja) * | 1996-04-15 | 2003-09-16 | 旭硝子株式会社 | ピペリジンカルビノール類の製造方法 |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
JP3882224B2 (ja) * | 1996-05-31 | 2007-02-14 | 旭硝子株式会社 | パロキセチンの製造方法 |
EP1384711A1 (en) * | 1996-06-13 | 2004-01-28 | SUMIKA FINE CHEMICALS Co., Ltd. | Optical resolution of a piperidine derivative |
HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
US5672609A (en) * | 1996-07-18 | 1997-09-30 | Eli Lilly And Company | Pyridine compounds, intermediates compositions and methods of use |
CA2187128A1 (en) * | 1996-10-04 | 1997-06-26 | K. S. Keshava Murthy | New and useful polymorph of anhydrous paroxetine hydrochloride |
EE03970B1 (et) * | 1997-06-10 | 2003-02-17 | Synthon B.V. | 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim |
CA2319652A1 (en) * | 1998-02-06 | 1999-08-12 | Michael Urquhart | Salts of paroxetine |
AU2847199A (en) * | 1998-03-16 | 1999-10-11 | Smithkline Beecham Plc | Crystalline form of paroxetine |
SK15032000A3 (sk) * | 1998-04-09 | 2001-04-09 | Smithkline Beecham Plc | Maleínan paroxetínu, spôsob jeho výroby a jeho použitie |
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
ES2159260B1 (es) * | 1999-06-22 | 2002-05-01 | Smithkline Beechan Plc | Nueva composicion de metanosulfonato de paroxetina |
DE20100529U1 (de) * | 2001-01-11 | 2001-05-10 | Synthon Bv | Pharmazeutische Tablette umfassend Paroxetinmesylat |
-
1999
- 1999-04-20 CH CH00723/99A patent/CH689805A8/fr not_active IP Right Cessation
- 1999-04-23 FR FR9905185A patent/FR2780728B1/fr not_active Expired - Fee Related
- 1999-04-23 NL NL1011874A patent/NL1011874C1/nl not_active IP Right Cessation
- 1999-04-23 SK SK2026-2000A patent/SK20262000A3/sk unknown
- 1999-04-23 CN CN99810281A patent/CN1127502C/zh not_active Expired - Fee Related
- 1999-04-23 AR ARP990101885A patent/AR011759A1/es not_active Application Discontinuation
- 1999-04-23 SI SI9930009T patent/SI1020464T1/xx unknown
- 1999-04-23 IE IE20000633A patent/IE20000633A1/en not_active IP Right Cessation
- 1999-04-23 EP EP99303151A patent/EP0970955B1/en not_active Revoked
- 1999-04-23 IT IT1999MI000866A patent/IT1312540B1/it active
- 1999-04-23 GB GB0026487A patent/GB2352395B/en not_active Expired - Fee Related
- 1999-04-23 ES ES99918159T patent/ES2209428T3/es not_active Expired - Lifetime
- 1999-04-23 GB GB0216752A patent/GB2377637A/en not_active Withdrawn
- 1999-04-23 DK DK99918159T patent/DK1089996T3/da active
- 1999-04-23 GR GR990100140A patent/GR990100140A/el not_active IP Right Cessation
- 1999-04-23 SI SI9930002T patent/SI0970955T1/xx unknown
- 1999-04-23 FI FI990922A patent/FI112077B/fi active
- 1999-04-23 EP EP00201289A patent/EP1020463A1/en not_active Withdrawn
- 1999-04-23 EP EP99918159A patent/EP1089996B1/en not_active Expired - Lifetime
- 1999-04-23 NZ NZ509180A patent/NZ509180A/en unknown
- 1999-04-23 SI SI9930482T patent/SI1089996T1/xx unknown
- 1999-04-23 NL NL1011875A patent/NL1011875C2/nl not_active IP Right Cessation
- 1999-04-23 PT PT79901275T patent/PT1020464E/pt unknown
- 1999-04-23 PT PT99918159T patent/PT1089996E/pt unknown
- 1999-04-23 AU AU23938/99A patent/AU713877B3/en not_active Ceased
- 1999-04-23 JP JP2000558097A patent/JP2002519422A/ja active Pending
- 1999-04-23 GB GB0119695A patent/GB2367003A/en not_active Withdrawn
- 1999-04-23 ES ES009900849A patent/ES2158778B1/es not_active Expired - Fee Related
- 1999-04-23 GB GB9920332A patent/GB2339428A/en not_active Withdrawn
- 1999-04-23 FI FI990190U patent/FI4209U1/fi not_active IP Right Cessation
- 1999-04-23 DE DE19918588A patent/DE19918588A1/de not_active Ceased
- 1999-04-23 TR TR2001/00054T patent/TR200100054T2/xx unknown
- 1999-04-23 DE DE69911774T patent/DE69911774T2/de not_active Expired - Fee Related
- 1999-04-23 AU AU23937/99A patent/AU713131B3/en not_active Ceased
- 1999-04-23 IE IE19990344A patent/IE990344A1/en not_active IP Right Cessation
- 1999-04-23 BR BR9911682-0A patent/BR9911682A/pt not_active Application Discontinuation
- 1999-04-23 DK DK99303151T patent/DK0970955T3/da active
- 1999-04-23 IE IE19990343 patent/IES81166B2/en not_active IP Right Cessation
- 1999-04-23 SE SE9901462A patent/SE9901462A0/sv not_active Application Discontinuation
- 1999-04-23 BE BE9900294A patent/BE1011664A6/fr not_active IP Right Cessation
- 1999-04-23 US US09/299,060 patent/US6063927A/en not_active Expired - Fee Related
- 1999-04-23 PL PL99345214A patent/PL345214A1/xx not_active Application Discontinuation
- 1999-04-23 EP EP02078483A patent/EP1288214A1/en not_active Withdrawn
- 1999-04-23 DK DK199900554A patent/DK199900554A/da not_active Application Discontinuation
- 1999-04-23 PT PT102291A patent/PT102291B/pt not_active IP Right Cessation
- 1999-04-23 KR KR1020007015099A patent/KR20010053336A/ko not_active Application Discontinuation
- 1999-04-23 PT PT99303151T patent/PT970955E/pt unknown
- 1999-04-23 DE DE29907248U patent/DE29907248U1/de not_active Expired - Lifetime
- 1999-04-23 AT AT0027999U patent/AT3185U3/de not_active IP Right Cessation
- 1999-04-23 WO PCT/GB1999/001253 patent/WO2000001694A1/en not_active Application Discontinuation
- 1999-04-23 CA CA002269999A patent/CA2269999A1/en not_active Abandoned
- 1999-04-23 EP EP00201290A patent/EP1020464B1/en not_active Revoked
- 1999-04-23 AT AT99303151T patent/ATE195121T1/de not_active IP Right Cessation
- 1999-04-23 AU AU36191/99A patent/AU3619199A/en not_active Abandoned
- 1999-04-23 GB GB9909505A patent/GB2336364B/en not_active Revoked
- 1999-04-23 IL IL14062899A patent/IL140628A/he not_active IP Right Cessation
- 1999-04-23 LU LU90388A patent/LU90388B1/fr active
- 1999-04-23 AT AT99918159T patent/ATE251155T1/de not_active IP Right Cessation
- 1999-04-23 IE IE20000893A patent/IES20000893A2/en not_active IP Right Cessation
- 1999-04-23 HU HU0102334A patent/HUP0102334A3/hu unknown
- 1999-04-23 DK DK199900176U patent/DK199900176U3/da not_active IP Right Cessation
- 1999-04-23 IE IE20000894A patent/IES20000894A2/en not_active Application Discontinuation
- 1999-04-23 AU AU23928/99A patent/AU732211C/en not_active Ceased
- 1999-04-23 DE DE69900007T patent/DE69900007T2/de not_active Revoked
- 1999-04-23 ES ES99303151T patent/ES2149044T3/es not_active Expired - Lifetime
- 1999-04-23 NO NO19991944A patent/NO319030B1/no unknown
- 1999-04-23 BE BE9900293A patent/BE1012403A5/fr not_active IP Right Cessation
- 1999-04-26 AR ARP990101908A patent/AR018197A1/es unknown
- 1999-06-08 NL NL1012271A patent/NL1012271C2/nl not_active IP Right Cessation
- 1999-06-08 NL NL1012272A patent/NL1012272C1/nl not_active IP Right Cessation
- 1999-06-15 DK DK199900234U patent/DK199900234U4/da not_active IP Right Cessation
- 1999-12-23 BE BE9900832A patent/BE1012420A6/fr not_active IP Right Cessation
-
2000
- 2000-04-10 DE DE60000003T patent/DE60000003T2/de not_active Revoked
- 2000-04-10 DK DK00201290T patent/DK1020464T3/da active
- 2000-04-10 AT AT00201290T patent/ATE202777T1/de not_active IP Right Cessation
- 2000-04-10 ES ES00201290T patent/ES2157881T3/es not_active Expired - Lifetime
- 2000-09-05 GR GR20000402015T patent/GR3034328T3/el not_active IP Right Cessation
- 2000-11-08 FR FR0014325A patent/FR2802098A1/fr active Pending
- 2000-12-27 DK DK200000390U patent/DK200000390U1/da not_active IP Right Cessation
-
2001
- 2001-03-14 US US09/805,812 patent/US20010023253A1/en not_active Abandoned
- 2001-07-11 GR GR20010401061T patent/GR3036208T3/el not_active IP Right Cessation
- 2001-09-21 US US09/960,033 patent/US20020035130A1/en not_active Abandoned
- 2001-10-11 HK HK01107165A patent/HK1037877A1/xx not_active IP Right Cessation
-
2002
- 2002-06-18 US US10/174,380 patent/US20020193406A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE195121T1 (de) | Paroxetinmethansulfonat | |
ATE341990T1 (de) | Sigmidoskop | |
DE59901560D1 (de) | Retrograder tibianagel | |
DE59902874D1 (de) | Buchsenkontakt | |
NO992430D0 (no) | R°rkobling | |
ID23761A (id) | Trisiklik tersubstitusi | |
NO992198D0 (no) | R°rledningspigg | |
ID23219A (id) | Trisiklik tersubstitusi | |
DE59903106D1 (de) | Tripode-gleichlaufdrehgelenk | |
DE69932936D1 (de) | Atemabsaugkathetervorrichtung | |
DE69938476D1 (de) | Münzschiebespielgerät | |
DE59901046D1 (de) | Methylcyclotetradec-5-en-1-one | |
DE59807217D1 (de) | Nadellager | |
DE19842103B4 (de) | Stanznietzuführung | |
DE59808995D1 (de) | Endomikroskopsystem | |
DE59903616D1 (de) | Rollenwicklerwalze | |
DE59900612D1 (de) | Dispersionsazofarbstoffmischungen | |
DE59902088D1 (de) | Achrathermer Reimager | |
ATE303996T1 (de) | Substituierte acylaminophenyl-uracile | |
DE59912188D1 (de) | Substituierte phenyluracile | |
DE59911610D1 (de) | Substituierte benzoylcyclohexandione | |
NO20005325D0 (no) | Bjelkelagskonstruksjon | |
DE59901263D1 (de) | Einzelplatz-sortierer | |
DE59903771D1 (de) | Hydro-transformator | |
NO983018D0 (no) | R°ranordning |